Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-22-009827
Filing Date
2022-09-09
Accepted
2022-09-09 12:30:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 35843
2 filename2.txt TEXT-EXTRACT 13297
  Complete submission text file 0000000000-22-009827.txt   63266
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filed for) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations